These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29308283)

  • 1. Targeting IL-17 in psoriatic arthritis.
    Wang EA; Suzuki E; Maverakis E; Adamopoulos IE
    Eur J Rheumatol; 2017 Dec; 4(4):272-277. PubMed ID: 29308283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?
    Megna M; Ocampo-Garza SS; Potestio L; Fontanella G; Gallo L; Cacciapuoti S; Ruggiero A; Fabbrocini G
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis.
    Alunno A; Carubbi F; Cafaro G; Pucci G; Battista F; Bartoloni E; Giacomelli R; Schillaci G; Gerli R
    Expert Opin Biol Ther; 2015; 15(12):1727-37. PubMed ID: 26653110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis.
    Furue K; Ito T; Furue M
    Cytokine; 2018 Nov; 111():182-188. PubMed ID: 30172115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
    Novelli L; Chimenti MS; Chiricozzi A; Perricone R
    Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.
    Raychaudhuri SP; Wilken R; Sukhov AC; Raychaudhuri SK; Maverakis E
    J Autoimmun; 2017 Jan; 76():21-37. PubMed ID: 27836567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glimpse on the role of IL-21 in psoriatic arthritis pathogenesis.
    Jose AM; Rasool M
    Life Sci; 2024 Aug; 350():122766. PubMed ID: 38834097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritis.
    Weitz JE; Ritchlin CT
    Expert Opin Biol Ther; 2014 Apr; 14(4):515-26. PubMed ID: 24555741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions.
    Li J; Liu L; Rui W; Li X; Xuan D; Zheng S; Yu Y; Zhang J; Kong N; Zhu X; Zou H; Wan W; Xue Y
    Dermatology; 2017; 233(1):37-46. PubMed ID: 28490011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis.
    Sakkas LI; Zafiriou E; Bogdanos DP
    Front Pharmacol; 2019; 10():872. PubMed ID: 31447673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data.
    Sakkas LI; Bogdanos DP
    Autoimmun Rev; 2017 Jan; 16(1):10-15. PubMed ID: 27666819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of psoriasis and psoriatic arthritis.
    Papoutsaki M; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis".
    Caso F; Postiglione L; Covelli B; Ricciardone M; Di Spigna G; Formisano P; D'Esposito V; Girolimetto N; Tasso M; Peluso R; Navarini L; Ciccozzi M; Margiotta DPE; Oliviero F; Afeltra A; Punzi L; Del Puente A; Scarpa R; Costa L
    Clin Rheumatol; 2019 Sep; 38(9):2547-2552. PubMed ID: 31147798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis.
    Durham LE; Kirkham BW; Taams LS
    Curr Rheumatol Rep; 2015 Aug; 17(8):55. PubMed ID: 26209291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review.
    Thibodaux RJ; Triche MW; Espinoza LR
    Expert Opin Biol Ther; 2018 Jul; 18(7):821-827. PubMed ID: 29949399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 and interleukin-23 inhibition in psoriatic arthritis.
    Johnsson HJ; McInnes IB
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S115-8. PubMed ID: 26471946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing rheumatoid arthritis from psoriatic arthritis.
    Merola JF; Espinoza LR; Fleischmann R
    RMD Open; 2018; 4(2):e000656. PubMed ID: 30167326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ustekinumab in psoriatic arthritis and related phenotypes.
    Dobbin-Sears I; Roberts J; O'Rielly DD; Rahman P
    Ther Adv Chronic Dis; 2018 Oct; 9(10):191-198. PubMed ID: 30263103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.